What is the Return on Assets (ROA) of Oxford Biomedica this year?
The Return on Assets (ROA) of Oxford Biomedica is -0.62 undefined this year.
Oxford Biomedica ROA 2025
Oxford Biomedica ROA
-0.62
Ticker
OXB.L
ISIN
GB00BDFBVT43
WKN
A2JLRX
In 2025, Oxford Biomedica's return on assets (ROA) was -0.62, a 633.47% increase from the -0.09 ROA in the previous year.
Oxford Biomedica Aktienanalyse
What does Oxford Biomedica do?
Oxford BioMedica PLC is a biopharmaceutical company based in Oxford, England. The company was founded in 1995 and has since become a leading provider of gene therapy products. The company's business model is to develop, produce, and market gene therapies for rare diseases and cancer. Oxford BioMedica utilizes modern technologies, such as viral vectors, to introduce genetic material into diseased cells and correct their function. One of the company's main areas of focus is the development of gene therapies for rare diseases. Oxford BioMedica has several promising products in this field, including gene therapies for metabolic disorders, muscular diseases, and eye diseases. Another important area for the company is the development of cancer immunotherapies. Oxford BioMedica is working on the development of gene therapies that activate the body's immune system to specifically target cancer cells. Among the products that Oxford BioMedica has already brought to market is the gene therapy product Strimvelis, which is used to treat severe combined immunodeficiency (SCID). Through treatment with Strimvelis, children with SCID can lead a normal life and are no longer confined to sterile environments. Another well-known product from Oxford BioMedica is the gene therapy product OXB-102, which is being tested in phase III clinical trials for the treatment of Parkinson's disease. In this therapy, a viral vector is used to correct a genetic mutation in the affected brain cells and alleviate the symptoms of Parkinson's. In recent years, Oxford BioMedica has also formed significant partnerships with major pharmaceutical and biotech companies such as Novartis, Sanofi, and Bioverativ to further develop and bring its gene therapy technology and products to market. Overall, Oxford BioMedica is a leading company in the field of gene therapy. With a strong pipeline of promising products and significant partnerships with the pharmaceutical industry, the company is well positioned to continue growing and contribute to the cure of diseases. Oxford Biomedica ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Oxford Biomedica's Return on Assets (ROA)
Oxford Biomedica's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Oxford Biomedica's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Oxford Biomedica's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Oxford Biomedica’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Oxford Biomedica stock
What was the ROA of Oxford Biomedica compared to the previous year?
The ROA of Oxford Biomedica has increased by 633.47% compared to the previous year.
What consequences do high ROA have for investors of Oxford Biomedica?
A high ROA is advantageous for investors of Oxford Biomedica, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Oxford Biomedica?
A low ROA can be unfavorable for investors of Oxford Biomedica as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Oxford Biomedica affect the company?
An increase in ROA of Oxford Biomedica can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Oxford Biomedica impact the company?
A reduction in the ROA of Oxford Biomedica can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Oxford Biomedica?
Some factors that can influence the ROA of Oxford Biomedica include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Oxford Biomedica important for investors?
The ROA of Oxford Biomedica is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Oxford Biomedica take to improve ROA?
To improve ROA, Oxford Biomedica can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Oxford Biomedica pay?
Over the past 12 months, Oxford Biomedica paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oxford Biomedica is expected to pay a dividend of 0 GBP.
What is the dividend yield of Oxford Biomedica?
The current dividend yield of Oxford Biomedica is .
When does Oxford Biomedica pay dividends?
Oxford Biomedica pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Oxford Biomedica?
Oxford Biomedica paid dividends every year for the past 0 years.
What is the dividend of Oxford Biomedica?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Oxford Biomedica located?
Oxford Biomedica is assigned to the 'Health' sector.
Wann musste ich die Aktien von Oxford Biomedica kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Oxford Biomedica from 1/24/2025 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 1/24/2025.
When did Oxford Biomedica pay the last dividend?
The last dividend was paid out on 1/24/2025.
What was the dividend of Oxford Biomedica in the year 2024?
In the year 2024, Oxford Biomedica distributed 0 GBP as dividends.
In which currency does Oxford Biomedica pay out the dividend?
The dividends of Oxford Biomedica are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Oxford Biomedica stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Oxford Biomedica
Our stock analysis for Oxford Biomedica Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oxford Biomedica Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- Oxford Biomedica Revenue
- Oxford Biomedica Net Income
- Oxford Biomedica P/E
- Oxford Biomedica P/S
- Oxford Biomedica EBIT
- Oxford Biomedica Dividend
- Oxford Biomedica Stocks
- Oxford Biomedica Market capitalization
- Oxford Biomedica Debt
- Oxford Biomedica Liabilities
- Oxford Biomedica Equity
- Oxford Biomedica AAQS
- Oxford Biomedica Employees
- Oxford Biomedica ROE
- Oxford Biomedica ROA
- Oxford Biomedica ROCE
